Tilray Inc buy shadow
Start price
04.05.21
/
0%
€14.11
Target price
04.05.22
-
Performance (%)
-64.48%
End price
05.05.22
€5.01
Summary
This prediction ended on 05.05.22 with a price of €5.01. Massive losses of -64.48% were the result for the BUY prediction by shadow. This prediction was marked as speculative and is excluded from shadow's performance statistics.Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Tilray Inc | -14.105% | -14.105% | -78.620% |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% |
According to shadow what are the pros and cons of Tilray Inc for the foreseeable future?
Pros
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Innovative
Some uniques
Small cyclical dependencies
Cons
Lower EBIT Margin than peer group
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Little known brand
Business model of the past or high risk
Comments by shadow for this prediction
In the thread Tilray Inc diskutieren
In the thread Trading Tilray Inc
Die von shadow gewählte maximale Laufzeit wurde überschritten
Stopped prediction by shadow for Tilray Inc
Tilray Inc
Start price
Target price
Perf. (%)
€16.78
15.01.21
15.01.21
-
15.01.22
15.01.22
-15.93%
04.05.21
04.05.21
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
